Revolution Medicines · 11 hours ago
Executive Director, Global Commercial Lead
San Francisco Bay Area
Full-time
Hybrid
Director/Executive
$256K/yr - $320K/yr
15+ years expRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Executive Director, Global Commercial Lead will drive global commercial strategy and oversee launch strategies for oncology products, collaborating cross-functionally to ensure successful execution.
Health CareLife ScienceMedical
Responsibilities
Partner across the company including with clinical development, medical affairs, market access, to drive indication strategy, shape brand strategies across the product team
Ensure global readiness to drive successful launch planning, commercialization, and performance tracking across the U.S. and key ex-U.S. markets
Execute global disease area strategy, brand strategies, including branding, positioning, messaging, and value propositions that guide regional affiliates and align with long-term portfolio goals
Translate scientific and market insights into compelling strategies, launch narratives, and execution plans; effectively communicating recommendations and leading strategic discussions with global and regional stakeholders
Develop and refine global brand plans, including revenue and patient forecasts, to inform investment decisions, lifecycle strategies, and portfolio prioritization
Drive excellence in global launch execution: creating launch frameworks, ensuring best practices are shared across affiliates, and monitoring progress to anticipate and resolve challenges
Identify and manage external agencies, vendors, and partners to deliver impactful global campaigns, educational initiatives, and engagement platforms
Serve as a trusted resource to executive leadership in identifying opportunities to maximize commercial value, expand indications, and differentiate in competitive markets
Bring innovation and new capabilities to global marketing—collaborate with IS Commercial to integrate digital, omnichannel, and data-driven approaches to build a best-in-class commercial function
Up to 50% of travel required
Qualification
Required
Bachelor's degree required (MBA preferred) with at least 15+ years of progressive commercial experience in a biotechnology and/or pharmaceutical company including strategic marketing and ideally sales
Proven success of developing and executing global marketing strategy
Experience in leading the global launch of new product in competitive spaces
Demonstrated ability to derive insights/analytics leading to the development of innovative marketing strategies
Strong leadership, with the ability to lead teams, work well cross-functionally, and influence across the organization to create a clear sense of direction
Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines
Ability to represent Revolution Medicines well externally: strong interpersonal skills including verbal and written communication
Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patients
Preferred
Experience with an oncology launch is desired
Prior experience in a smaller, rapidly growing, company
Experience in gastrointestinal or lung cancer preferred
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
501-1000 employees
H1B Sponsorship
Revolution Medicines has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (18)
2023 (15)
2022 (8)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Leadership Team
Luan Wilfong
Chief Human Resources Officer
Steve Kelsey
President
Recent News
2025-12-18
2025-12-18
Company data provided by crunchbase